The health official behind the pause of the NHS’s puberty blocker trial is blocked from any further involvement amid accusations of bias.

Ananda's CEO, Melissa Sturgess commented: "The personal and societal burden of endometriosis is staggering and it is appalling that more is not being done to find useful treatments for this ...

The Medicines and Healthcare products Regulatory Agency has approved imlunestrant tosylate, branded as Inluriyo, for adults ...

What is Inluryo, and who can benefit from it? Learn about this newly approved breast cancer treatment and how it works.

As with all clinical trials, the MHRA's top priority is the safety and wellbeing of the trial participants. An MHRA spokesperson said: "With all ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Eylea (aflibercept 8mg, 114.3 ...

The Medicines and Healthcare products Regulatory Agency has issued a recall for a single batch of Ramipril 5 mg Capsules manufactured by Crescent Pharma Limited. The precautionary measure concerns ...

Upperton has formally submitted its application to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for approval of its 7,000 sq. ft sterile manufacturing facility. This submission ...

The Medicines and Healthcare products Regulatory Agency (MHRA) will evaluate the possibility of extending recognition of CE-marked medical devices beyond the current 2030 deadline, marking a potential ...